The Regulator

A federal judge blocked eight provisions of a Trump administration health insurance rule two business days before they were set to take effect, provisions the Centers for Medicare and Medicaid Services itself estimated could cost up to 2 million people their Affordable Care Act marketplace coverage. U.S. District Judge Brendan Hurson ruled July 16, 2026 in City of Columbus et al. v. Kennedy et al., known as Columbus II, a case brought by the cities of Columbus, Chicago, and Baltimore, Pima County, Arizona, and advocacy groups Doctors for America and Main Street Alliance challenging CMS’s 2027 Notice of Benefit and Payment Parameters final rule. The stayed provisions, due to take effect July 20, 2026, would have disqualified consumers who fail to reconcile prior tax credits with their income from future subsidies, imposed stricter income verification before enrollment, tightened special enrollment period eligibility checks, raised the out of pocket cap for bronze plans, eliminated standardized plan requirements, relaxed network adequacy standards, and expanded catastrophic coverage eligibility. Hurson found the plaintiffs were likely to succeed on their claim that CMS exceeded its rulemaking authority under the Administrative Procedure Act. Confidence: High on the provisions and ruling date; Low on how the litigation ultimately resolves, since the government can appeal. Sources: City of Columbus et al. v. Kennedy et al. (Columbus II), Health Care Litigation Tracker, Georgetown University O’Neill Institute, Judge stays Trump administration policies set to shrink ACA marketplaces, Healthcare Dive.

The Food and Drug Administration and the Centers for Disease Control and Prevention traced a five state Cyclospora outbreak that has sickened 1,644 people and hospitalized 94 to shredded iceberg lettuce served at Taco Bell, prompting the supplier to pull all lettuce sourced from central Mexico. The agencies reported July 16 and 17, 2026 that illnesses began as early as May 13 and continued through July 13 among people who ate at Taco Bell locations in Indiana, Kentucky, Michigan, Ohio, and West Virginia, and that FDA’s traceback investigation converged on a single supplier, Taylor Farms de Mexico. Taylor Farms announced July 17 it would voluntarily withdraw all iceberg lettuce sourced from central Mexico and told FDA it would initiate a recall; Taco Bell said it has stopped using lettuce from the identified supplier. No deaths have been reported. Confidence: High on the case count, hospitalization figure, and affected states, since both agencies confirm the same numbers; Medium on whether the supply chain fix fully resolves the outbreak, since a formal recall notice had not yet posted as of this writing. Sources: Investigation of 5-State Outbreak of Cyclospora Illnesses: Iceberg Lettuce, U.S. Food and Drug Administration, Cyclospora Outbreak Linked to Shredded Iceberg Lettuce Served at Taco Bell in 5 States, Centers for Disease Control and Prevention.

Pennsylvania’s new state budget delays roughly 2.6 billion dollars in Medicaid managed care payments to plans like Geisinger and UPMC over two years, an accounting maneuver the state’s own fiscal watchdog says could create cash flow problems for the companies covering low income residents. The Independent Fiscal Office’s July 14, 2026 budget update describes a “cycle roll” that pushes two consecutive monthly payment cycles, about 1.3 billion dollars each, later than scheduled, a compromise Democratic lawmakers accepted after Republican state senators refused Governor Josh Shapiro’s push to draw down the state’s rainy day fund. Independent Fiscal Office director Matthew Knittel warned the move does not address Pennsylvania’s roughly 5 billion dollar structural deficit and could strain managed care organizations’ cash flow; state Senator Jarrett Coleman called the practice “dishonest.” No fixed repayment date has been set. Confidence: High on the dollar figures and the Independent Fiscal Office’s warning; Low on whether or when the delayed payments resume on schedule, since the budget does not specify a repayment date. Sources: General Fund Budget Update, Pennsylvania Independent Fiscal Office, Pennsylvania’s new budget relies on accounting tricks, delayed Medicaid payments to close its deficit, Spotlight PA.

A couple who fled Ohio for Kenya or Ghana is charged with stealing 9.3 million dollars from Medicaid by billing for mental health counseling that refugees resettling in the state never received, one of eleven Medicaid fraud cases Ohio’s Attorney General announced the same day. Roberta Acheampong, 39, and Godfred Owusu-Sekyere, 46, former operators of One Community Mental Health in the Columbus area, face 12 felony counts including engaging in a pattern of corrupt activity, Medicaid fraud, money laundering, and identity fraud; prosecutors say the pair billed Medicaid multiple times a week for services never provided, forged documents, and stole staff identities to submit false claims, then spent the proceeds on real estate and a Porsche. Ohio Attorney General Dave Yost’s office announced the same day, July 15, 2026, that ten additional home health and behavioral health providers were indicted separately for a combined 563,860 dollars in Medicaid losses, including billing for services during vacations, while hospitalized, or while working other jobs. Confidence: High on the charges and dollar figures as alleged by prosecutors; Low on the outcome, since all defendants are presumed innocent until proven guilty and the lead defendants have not been apprehended. Source: Couple Who Used to Live in Powell Indicted in $9.3 Million Medicaid Fraud Scheme, Ohio Attorney General.

Fifty three of the nation’s fifty five organ procurement organizations jointly proposed a new eight measure quality framework to replace the two metric system CMS uses to decide which organizations lose their federal certification, a preemptive move as CMS enforcement of its 2020 decertification rule intensifies. The Association of Organ Procurement Organizations published the framework July 17, 2026, proposing measures covering referral rate, approach rate, authorization rate, donation rate, donor management, organs recovered per donor, organ utilization rate, and safety, and has already submitted the first four measures to the Partnership for Quality Measurement for formal endorsement. The group argues CMS’s current donation rate and transplantation rate metrics do not account for regional differences and hold organizations accountable for factors outside their control, at a time when CMS decertification enforcement is expected to reach nearly every organ procurement organization in the country this year. Confidence: High on the framework’s content and the number of participating organizations; Low on whether CMS adopts any of the proposed measures, since the endorsement and rulemaking process has just begun. Source: AOPO Guidance on the Alignment and Use of Organ Procurement Organization Quality and Performance Measures, Association of Organ Procurement Organizations.

The FDA approved the first pill that lowers cholesterol by blocking PCSK9, short for proprotein convertase subtilisin/kexin type 9, a protein that has only been targetable with injectable drugs until now, giving people with high cholesterol a once daily oral alternative to needles. The Food and Drug Administration approved Lipfendra, known chemically as enlicitide, on July 16, 2026 for adults with high LDL cholesterol, including the inherited condition heterozygous familial hypercholesterolemia; the drug, made by Merck, cut LDL cholesterol by 56 percent in a 2,904 patient trial and by 59 percent in a 303 patient trial of familial hypercholesterolemia patients after 24 weeks, matching the efficacy of injectable PCSK9 inhibitors already on the market. FDA granted the approval Priority Review; the most common side effects were diarrhea and dizziness. Confidence: High on the approval and trial results; Low on how insurers, including Medicare Part D plans, will price and cover the drug relative to injectable competitors, since coverage decisions have not been announced. Source: FDA Approves First Oral Therapy that Inhibits Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) to Lower Bad Cholesterol in Adults with High Cholesterol, U.S. Food and Drug Administration.

A government watchdog found the share of clinicians using artificial intelligence tools to draft medical notes or generate insurance codes grew from 21 percent to 28 percent in two years, and warned that unverified AI errors could trigger patient harm or over- and under-billing. The Government Accountability Office published its “AI for Medical Notes and Coding” spotlight July 16, 2026, citing American Medical Association survey data on the adoption jump and noting one unnamed provider’s implementation reached over 95 percent accuracy while cutting more than 1 million dollars in annual coding costs, but flagging that independent verification of these tools’ accuracy remains limited, that under-resourced facilities may struggle to afford them, and that federal agencies and insurers have not settled how to oversee AI coding tools to ensure appropriate reimbursement. GAO’s report does not issue formal recommendations but frames the oversight questions CMS and other regulators will need to answer. Confidence: High on the adoption statistics, since they are sourced to American Medical Association survey data; Low on any near term regulatory response, since GAO’s report raises questions rather than proposing a specific rule. Source: Science and Tech Spotlight: AI for Medical Notes and Coding, U.S. Government Accountability Office.